Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Aug 5, 2020
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-08-04$4.11/sh−92$378→ 17,753 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 08/01/2020.